THE United States Agency for International Development (USAID), in partnership with the U.S. National Academies of Science, Engineering, and Medicine, will dedicate $12 million to support the expansion of programs, to prevent cervical cancer in the Republics of Malawi and Mozambique through integrated programs to improve women’s health.
Cervical cancer is an outcome of infection with the human papillomavirus (HPV). To reduce cervical cancer in Malawi and Mozambique, USAID will fund activities through the following partnerships:
Cervical cancer has become one of the largest killers of women in the developing world; 283,000 women die of the disease each year in low and middle income nations. Malawi and Mozambique have the highest and second-highest cervical cancer in the world, respectively.
This is the first time USAID has funded programs to prevent cervical cancer in the context of broader women’s health, other than under the President’s Emergency Plan for AIDS Relief (PEPFAR). These new programs in Malawi and Mozambique will coordinate closely with PEPFAR investments in both countries.
USAID helps developing countries along their Journey to Self-Reliance by the strengthening the delivery of care, as well as the capacity for research and collaboration within higher-education institutions. Our goal is to enable countries to build their commitment and capacity to plan, finance, and implement solutions to their own development challenges.